Literature DB >> 25895461

VEGFR1 and VEGFR2 in lip carcinogenesis and its association with microvessel density.

Carla Ariotti1, Vivian Petersen Wagner1, Gabriela Salvadori2, Vinicius Coelho Carrard1, Marco Antônio Trevizani Martins3, Joao Julio da Cunha Filho4, Luise Meurer5, Manoela Domingues Martins6,7.   

Abstract

The aim of the present study was to determine the role of vascular endothelial growth factor receptors (VEGFR1 and VEGFR2) in lip carcinogenesis, to investigate correlations between these markers with microvessel density (MVD) and clinicopathological aspects. Medical records from 27 cases of actinic cheilitis (AC) and 46 cases of lower lip squamous cell carcinoma (LLSCC) were analysed and submitted to immunohistochemistry. VEGFR1- and VEGFR2-immunostained sections were analysed based on percentage of positive epithelial and inflammatory cells, while CD31 was submitted to quantitative analysis to determine MVD. Different patterns of VGFR1 and VEGFR2 expression were observed between AC and LLSCC. VEGFR1 expression in epithelial and inflammatory cells and VEGFR2 expression in epithelial cells were higher in AC compared to LLSCC (p < 0.05). VEGFR1 expression in epithelial cells was higher in LLSCC compared to AC (p < 0.001). Expression of both receptors was not associated to MVD or clinicopathological aspects. A direct correlation was found between epithelial VEGFR1 and VEGFR2 expression (p = 0.02) and between VEGFR2 epithelial and inflammatory expression (p < 0.001). Our findings indicate that activation of VEGFR1 and VEGFR2 in epithelial and inflammatory cells appears to be an early event in lip carcinogenesis.

Entities:  

Keywords:  Actinic cheilitis; Angiogenesis; Oral squamous cell carcinoma; Potentially malignant disorders; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 25895461     DOI: 10.1007/s13277-015-3454-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

1.  World Health Organization classification of tumours: pathology and genetics of head and neck tumours.

Authors:  Lester Thompson
Journal:  Ear Nose Throat J       Date:  2006-02       Impact factor: 1.697

2.  Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation.

Authors:  D Ravi; K Ramadas; B S Mathew; K R Nalinakumari; M K Nair; M R Pillai
Journal:  Oral Oncol       Date:  1998-11       Impact factor: 5.337

3.  VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study.

Authors:  A C Stîngă; Otilia Mărgăritescu; Alina Simona Stîngă; D Pirici; Raluca Ciurea; Adina Bunget; M Cruce
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

4.  Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma.

Authors:  M Moriyama; S Kumagai; S Kawashiri; K Kojima; K Kakihara; E Yamamoto
Journal:  Oral Oncol       Date:  1997-09       Impact factor: 5.337

5.  Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation.

Authors:  J Carlile; K Harada; R Baillie; M Macluskey; D M Chisholm; G R Ogden; S L Schor; A M Schor
Journal:  J Oral Pathol Med       Date:  2001-09       Impact factor: 4.253

6.  Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells.

Authors:  Y Michi; I Morita; T Amagasa; S Murota
Journal:  Oral Oncol       Date:  2000-01       Impact factor: 5.337

7.  Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

8.  Spatiotemporal assessments of dermal hyperemia enable accurate prediction of experimental cutaneous carcinogenesis as well as chemopreventive activity.

Authors:  Raymond L Konger; Zhengbin Xu; Ravi P Sahu; Badri M Rashid; Shama R Mehta; Deena R Mohamed; Sonia C DaSilva-Arnold; Joshua R Bradish; Simon J Warren; Young L Kim
Journal:  Cancer Res       Date:  2012-10-29       Impact factor: 12.701

9.  Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.

Authors:  Rajesh V Lalla; David S Boisoneau; Jeffrey D Spiro; Donald L Kreutzer
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-08

10.  VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.

Authors:  Z Zhang; K G Neiva; M W Lingen; L M Ellis; J E Nör
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

View more
  3 in total

Review 1.  Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.

Authors:  Peijie Wu; Wei Gao; Miao Su; Edouard C Nice; Wenhui Zhang; Jie Lin; Na Xie
Journal:  Front Cell Dev Biol       Date:  2021-03-01

Review 2.  Advances in studies of tyrosine kinase inhibitors and their acquired resistance.

Authors:  Qinlian Jiao; Lei Bi; Yidan Ren; Shuliang Song; Qin Wang; Yun-Shan Wang
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

3.  Can immunohistochemical biomarkers distinguish epithelial dysplasia degrees in actinic cheilitis? A systematic review and meta-analysis.

Authors:  T Santana; B Matuck; J-R Tenório; M-M Braga
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.